ASX [ADVANCED SEMICONDUCTOR ENGINEERING] 6-K: (Original Filing)
[Note: X Yes ___ No Not applicable]
[Note: X Yes ___ No Not applicable]
[Yingli Green Energy Reports Fourth Quarter and Full Year 2009 Results Fourth Quarter PV Module Shipmentsreased by 15.7% Quarter over Quarter BAODING, China, March8, 2010 Fourth Quarter 2009nsolidated Financial and Operating Highlights Total net revenues were RMB 2,530.9million (US$370.8million) and PV module shipment volumereased by 15.7% quarter over quarter, reaching a historical high.] [Yingli Green Energy Announces 300 MW PANDA Mono-Crystalline BAODING, China, March8, 2010 300 MW PANDA Mono-Crystalline Manufacturingpacity Expansion at Baoding Headquarters Yingli Green Energy announced its plan to build PANDA mono-crystalline silicon-based manufacturing lines with annual productionpacity of 300 MW in each of mono-crystalline ingots and wafers, cells and modules at its Baoding headquarters, through]
[Note: X Yes ___ No Not applicable]
[Yingli Green Energy Reports Fourth Quarter and Full Year 2009 Results Fourth Quarter PV Module Shipmentsreased by 15.7% Quarter over Quarter BAODING, China, March8, 2010 Fourth Quarter 2009nsolidated Financial and Operating Highlights Total net revenues were RMB 2,530.9million (US$370.8million) and PV module shipment volumereased by 15.7% quarter over quarter, reaching a historical high.] [Yingli Green Energy Announces 300 MW PANDA Mono-Crystalline BAODING, China, March8, 2010 300 MW PANDA Mono-Crystalline Manufacturingpacity Expansion at Baoding Headquarters Yingli Green Energy announced its plan to build PANDA mono-crystalline silicon-based manufacturing lines with annual productionpacity of 300 MW in each of mono-crystalline ingots and wafers, cells and modules at its Baoding headquarters, through]
[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]
[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]
[v176570_ex99-1.htm 2 EX-99.1]
[v176570_ex99-1.htm 2 EX-99.1]